94 related articles for article (PubMed ID: 21736398)
1. Molecular targets in the design of antifibrotic therapy in chronic liver disease.
Solís Herruzo JA; Solís-Muñoz P; Muñoz Yagüe T; García-Ruiz I
Rev Esp Enferm Dig; 2011 Jun; 103(6):310-23. PubMed ID: 21736398
[No Abstract] [Full Text] [Related]
2. Cytokines and renin-angiotensin system signaling in hepatic fibrosis.
Moreno M; Bataller R
Clin Liver Dis; 2008 Nov; 12(4):825-52, ix. PubMed ID: 18984469
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of naringenin in liver diseases: Molecular mechanisms.
Hernández-Aquino E; Muriel P
World J Gastroenterol; 2018 Apr; 24(16):1679-1707. PubMed ID: 29713125
[TBL] [Abstract][Full Text] [Related]
4. Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells.
Zhao XY; Zeng X; Li XM; Wang TL; Wang BE
Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):963-8. PubMed ID: 19413596
[TBL] [Abstract][Full Text] [Related]
5. How to modulate inflammatory cytokines in liver diseases.
Tilg H; Kaser A; Moschen AR
Liver Int; 2006 Nov; 26(9):1029-39. PubMed ID: 17032402
[TBL] [Abstract][Full Text] [Related]
6. Expression and potential role of the extracellular matrix in hepatic ontogenesis: a review.
Amenta PS; Harrison D
Microsc Res Tech; 1997 Nov; 39(4):372-86. PubMed ID: 9407547
[TBL] [Abstract][Full Text] [Related]
7. [Effects of rosiglitazone on expression of collagen I and tissue inhibitor of metalloproteinase 1 in rat hepatic stellate cells].
Feng YS; Ma H; Yue LP
Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):66-7. PubMed ID: 19203458
[No Abstract] [Full Text] [Related]
8. Alcohol and liver fibrosis.
Cubero FJ; Urtasun R; Nieto N
Semin Liver Dis; 2009 May; 29(2):211-21. PubMed ID: 19387920
[TBL] [Abstract][Full Text] [Related]
9. [Extracellular matrix, hepatic fibrosis and anti-fibrosis treatment].
Geubel AP
Acta Gastroenterol Belg; 1990; 53(2):216-24. PubMed ID: 2267901
[TBL] [Abstract][Full Text] [Related]
10. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
11. Regression of liver fibrosis by taurine in rats fed alcohol: effects on collagen accumulation, selected cytokines and stellate cell activation.
Devi SL; Viswanathan P; Anuradha CV
Eur J Pharmacol; 2010 Nov; 647(1-3):161-70. PubMed ID: 20813107
[TBL] [Abstract][Full Text] [Related]
12. [Recent studies on Ito cells with molecular biology].
Enzan H; Himeno H; Saibara T; Hara H
Nihon Rinsho; 1993 Feb; 51(2):472-81. PubMed ID: 8464160
[TBL] [Abstract][Full Text] [Related]
13. Fibrosis in the liver: acute protection and chronic disease.
Lee Y; Friedman SL
Prog Mol Biol Transl Sci; 2010; 97():151-200. PubMed ID: 21074733
[TBL] [Abstract][Full Text] [Related]
14. Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-beta-mediated profibrotic gene expression pattern.
Ruehl M; Erben U; Kim K; Freise C; Dagdelen T; Eisele S; Trowitzsch-Kienast W; Zeitz M; Jia J; Stickel F; Somasundaram R
J Nutr Biochem; 2009 Aug; 20(8):597-606. PubMed ID: 18824344
[TBL] [Abstract][Full Text] [Related]
15. Effect of aldosterone on collagen steady state levels in primary and subcultured rat hepatic stellate cells.
Rombouts K; Niki T; Wielant A; Hellemans K; Schuppan D; Kormoss N; Geerts A
J Hepatol; 2001 Feb; 34(2):230-8. PubMed ID: 11281551
[TBL] [Abstract][Full Text] [Related]
16. Fibrosis in chronic liver disease.
Popper H; Kent G
Clin Gastroenterol; 1975 May; 4(2):315-32. PubMed ID: 1092488
[No Abstract] [Full Text] [Related]
17. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis.
Baroni GS; D'Ambrosio L; Curto P; Casini A; Mancini R; Jezequel AM; Benedetti A
Hepatology; 1996 May; 23(5):1189-99. PubMed ID: 8621153
[TBL] [Abstract][Full Text] [Related]
18. Antifibrotic properties of botanicals in chronic liver disease.
Stickel F; Brinkhaus B; Krähmer N; Seitz HK; Hahn EG; Schuppan D
Hepatogastroenterology; 2002; 49(46):1102-8. PubMed ID: 12143213
[TBL] [Abstract][Full Text] [Related]
19. Study on antifibrotic effects of curcumin in rat hepatic stellate cells.
Lin YL; Lin CY; Chi CW; Huang YT
Phytother Res; 2009 Jul; 23(7):927-32. PubMed ID: 19152370
[TBL] [Abstract][Full Text] [Related]
20. Hepatic stellate cell behavior during resolution of liver injury.
Iredale JP
Semin Liver Dis; 2001 Aug; 21(3):427-36. PubMed ID: 11586470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
